Advertisement

Topics

Congenital Heart Disease Pipeline Insight, 2018 [Report Updated: 14022018] Prices from USD $1500

08:03 EDT 14 Mar 2018 | BioPortfolio Reports

"Congenital Heart Disease Pipeline Insight, 2018 report by DelveInsight offers comprehensive Insight of the pipeline under development therapeutics scenario and growth prospects across Congenital Heart Disease development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.


Pipeline Products covered across the following Developmental Stages:

Clinical

Nonclinical

Inactive: Discontinued and/or Dormant


Descriptive coverage of pipeline development activities for Congenital Heart Disease

Pipeline therapeutics development coverage provides descriptive product profiles including but not limited to drug description, product development and RD activities encompassing clinical and preclinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.


Pipeline Therapeutics assessment of products for Congenital Heart Disease

The report assesses the active Congenital Heart Disease pipeline products by developmental stage, product type, molecule type, and administration route.


Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and inhouse analysis by DelveInsight's team of industry experts.

Information and data from the secondary sources have been obtained from various printable and nonprintable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.


Scope of the report

The report provides a snapshot of the pipeline development for the Congenital Heart Disease

The report covers pipeline activity across the complete product development cycle i.e. clinical, preclinical and discovery stages for the Congenital Heart Disease

The report provides pipeline product profiles which includes product description, developmental activities, licensors collaborators and chemical information

Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Congenital Heart Disease

The report also covers the dormant and discontinued pipeline projects related to the Congenital Heart Disease


Reasons to Buy

Establish comprehensive understanding of the pipeline activity across this Congenital Heart Disease to formulate effective RD strategies

Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine

Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Congenital Heart Disease therapeutics

Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Original Article: Congenital Heart Disease Pipeline Insight, 2018 [Report Updated: 14022018] Prices from USD $1500

NEXT ARTICLE

More From BioPortfolio on "Congenital Heart Disease Pipeline Insight, 2018 [Report Updated: 14022018] Prices from USD $1500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...